Your trusted source for investing success

Tag: pharmaceutical

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
 
What Is In-Licensing?

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions.

Moleculin Announces Pricing of $9 Million Registered Direct Offering

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center, announced that it has entered into a definitive agreement with institutional investors

Knight Therapeutics and SIFI Announce Filing of New Drug Submission

Knight Therapeutics (TSX:GUD) a leading Canadian specialty pharmaceutical company, and S.I.F.I- Società Industria Farmaceutica Italiana S.p.A., a prominent Italian Eye Care company, today announced that Knight’s New Drug Submission for NETILDEX™ has been accepted for review by Health Canada. NETILDEX™ is a fixed combination of netilmicin and dexamethasone for the

Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti

Evoke Pharma (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) d­­iseases, today announced additional findings from its comparative exposure pharmacokinetic (PK) trial for Gimoti™, the Company’s novel nasal spray delivery of metoclopramide for the treatment of symptoms associated with gastroparesis. Further analysis of the PK data by sex

Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results

Ohr Pharmaceutical (Nasdaq:OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results and operating highlights for its fiscal first quarter ended December 31, 2017.

As quoted in the press release:
“We recently announced top-line results from the MAKO study evaluating the efficacy and safety of topically administered squalamine in

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc.

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc.

Isodiol International Inc. (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc. (CN Pharma), a pharmaceutical manufacturing company.

Teligent Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented)

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%.

As quoted in the press release:
“Betamethasone Dipropionate Lotion USP (Augmented), 0.05% is Teligent’s

Opiant Pharmaceuticals Announces Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced positive data from a Phase I clinical study of its product candidate OPNT003 and provided an update on a meeting held February 8, 2018 with the U.S. Food and Drug Administration (FDA) regarding its planned development

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
How to Invest in a Cannabis Stock

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/how-to-invest-in-a-cannabis-stock/